Silacyclic derivatives of heteroaromatic sulfides have been prepared by using phase transfer catalytic (PTC) system thiol / silacyclopropyl iodide / solid K2CO3 / 18-crown-6 / toluene. The target sulfides were isolated in yields up to 70 %. The S-derivatives of N-methylimidazolyl, benzoxazolyl and 1,3,4-triazolyl thiols selectively lowered the low density lipoprotein (LDL) level in mice with the high cholesterol diet in nutrition.
INTRODUCTION
Recently the activity of a wide spectrum of heteroaromatic sulfides on the heart and blood circulatory system was described [1] . For example, quinoline sulfides exhibit antihypertensive [2] [3] [4] , vasodilating [2] [3] , hypotensive [5, 6] , euglicemic and hypolipidemic [7] , antithrombotic [8] , cardiotonic [9] , cardiovascular [10] [11] [12] and cholesterol- [13] and blood sugar lowering [14] activities and may be used in the treatment of diabetes [15] [16] [17] and arthritis [18] . Thiazole and benzothiazole sulfides display vasodilating [19] , hypotensive [20] and antihyperglycemic and antihyperlipidemic [21] activities. Imidazole and benzimidazole sulfides exhibit vasodilating [22] , antihypertensive [23] , hypoglycemic [24] , antithrombotic [25] , cardiotonic [26, 27] , cardiovascular [28] , cholesterol [29] [30] [31] and blood sugar lowering [32] , antidiabetic [33, 34] activities, increase high density lipoprotein cholesterol over lipid fractions [35] and were used in the treatment of atherosclerosis [36] [37] [38] [39] and osteoarthritis [40] . Triazole sulfides were used in the treatment of high blood pressure and heart failure [41] and display platelet activator and antithrombotic [42] activities. Oxazole sulfides exhibit an antihypertensive [43] activity. Indole sulfur derivatives were used in the treatment of atherosclerosis [44] , arthritis [45, 46] , diabetic complications [47] and congestive hearth failure [48] .
In our previous work the cholesterol level lowering and vasodilating activities of silicon and germanium containing aliphatic derivatives of heteroaromatic sulfides were studied [1] . The 1-methylimidazole, benzothiazole and 2-quinoline derivatives exhibited the highest level of activity. The compounds containing dimethyl(l$-triethylgermylethyl)silylmethyl and dimethyl(l$-triphenylsilylethyl)silylmethyl substituents were the most active in mice with the high cholesterol diet in nutrition. It was also shown that aliphatic silyl and germyl 1-methylimidazole derivatives possess a considerable vasodilating activity.
In continuation of our investigations in the field of cholesterol lowering agents the silacyclic Sderivatives of N-, O-and S-heterocycles have been synthesized under PTC conditions for the purpose to increase the heterocyclic sulfides lipophility and selectivity of action on the high and low density lipoproteins. The purity of the synthesized compounds was determined by HPLC (<1.5% of impurities). All substances were mobile oils therefore the elemental analysis was not performed.
MATERIALS AND METHODS
The structures and spectral characteristics of synthesized substances are shown in Tables 2 and 3. PHARMACOLOGY CHOLESTEROL LEVEL LOWERING ,4CTIVITY The The silacyclic imidazole derivative 8 has better K value (K 0.111) than the corresponding trimethylsilylpropyl analogue (K--0.453) [1] . Moreover, compound 8 show the tendency to increase the HDL level. This fact indicates that this compound can possess an additional positive influence.
The activity of the silacyclic substituted benzothiazole 10 (K 0.200) slightly differs from 2-(3-trimethylsilylpropyl)thiobenzothiazole (K 0.285) [1] . The insertion of a methylene group into the fivemembered silacyclopentane ring leads to decrease of activity (atherogenecity coefficient K=0.200 for 10 and K=0.401 for 11).
It is significant to note that benzoxazole derivative 9 is 3 times more active than benzothiazole derivative 10.
V,4SODIL,4 TING ,4 CTIVITY The vasodilating activity of the studied compounds in experiments in vivo is presented in the Table 4 . In general the studied silacyclic compounds have a weak influence on vasodilatation even in a 50tag/mL dose. It was found that imidazole derivative 8 exhibits the highest relaxation effect (18% in 10 lag/mL). It is more active than aliphatic silicon-containing analogues (12-13%), but less active than dimethyl(ltriethylgermylethyl)silylmethyl substituted imidazole (22%) ]. Kira (13) , 274 (17) , 265 (14) , 264 (12) , 263 (18) , 251 (24) , 250 (39) , 237 (67), 236 (51), 232 (15) , 223 (18) , 22 (74), 209 (29) , 193 (27) , 179 (12) , 167 (88), 162 (100), 150 (12) , 149 (62), 135 (21) , 122 (14) , 117 (21) , 109 (12) , 108 (33) , 102 (17) , 99 (58), 97 (52), 95 . (13), 75 (28) , 69 (26) , 59 (44) , 45 (76), 43 (72) 321 (M*, 10) , 278 (100), 250 (26) , 237 (30) , 236 (28) , 223 (21) , 194 (10) , 167 (40) , 136 (15) , 113 (15) , 108 (15) , 85 (46) , 69 (11) , 59 (24) , 45 (28) , 43 (27) 301 (M*, 14) , 286 (14) , 272 (42) , 254 (51), 244 (61), 230 (27) , 217 (24) , 99 (38) , 89 (20) , 71 (36) , 59 (24) , 43 (49) 331 (M*-SiMe(CH2)5, 10), 303 (11) , 149 (45) , 117 (100), 113 (90), 187 (100), 85 (82), 59 (70) 416 (M*-Me, 5) , 415 (14) , 304 (8) , 261 (31) , 248 (37) , 234 (13) , 191 (9) , 150 (25) , 113 (38) , 85 (1 00), 59 (34), 43 (22) 381 (M*, 21) , 380 (M*-I, 6) , 351 (18) , 340 (18) , 324 (10) , 310 (12) , 298 (18) , 284 (15) , 282 (14) , 264 (12) , 242 (42) , 212 (17) , 210 (14) , 200 (35) (35) ,. 45 (32) , 43 (33) 381 (M*, 10) , 366 (M*-Me, 10) , 353 (20) , 325 (60), 344 (26) , 339 (16) , 325 (18) , 324 (32) , 320 (14) , 305 (16) , 292 (18) , 282 (16) , 268 (12) , 242 (15) , 240 (15) , 226 (16) , 212 (27) , 200 (15) , 186 (16) , 170 (15) , 142 (15) , 128 (10) , 117 (34) , 99 (100), 97 (64), 85 (20) , 71 (85), 59 (32) , 45 (27) , 43 (3) 
ACUTE TOXICITY
The studied compounds have basically a low acute toxicity (Table 4) . Only imidazole sulfide exhibits a medium level oftoxicity (375 mg/kg).
CONCLUSIONS
A PTC method of synthesis of silacyclic derivatives of the N-, O-and S-heterocyclic sulfides was elaborated. Nine compounds were synthesized and isolated in the yields up to 70%.
They were studied as serum cholesterol level lowering agents. It has been found, that silacyclopentylpropylthio-imidazole ($), -benzoxazole (9), -benzothiazole (10) and -1,2,4-triazole (15b) exhibited a high antiatherosclerotic activity. It protected against increase in serum LDL cholesterol level. A preliminary analysis of the structure-activity relationship for the cholesterol lowering action clearly indicates the strong influence of the silacyclic substituent position in the triazole ring. Imidazole derivative $ has shown the tendency to increase the HDL level. This fact indicates that compound can possess an additional positive influence. The synthesized sulfides are low toxic compounds with weak vasodilating activity.
